Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Technologies, Inc. - Common Stock (NQ:IRTC)

158.50 -2.49 (-1.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 397,626
Open 161.25
Bid (Size) 150.00 (2)
Ask (Size) 180.00 (1)
Prev. Close 160.99
Today's Range 158.30 - 163.98
52wk Range 55.92 - 168.32
Shares Outstanding 29,403,360
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Unpopular Stocks We Find Risky
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Topics Economy
iRhythm Technologies Inc (NASDAQ:IRTC) Fits Mark Minervini’s Trend-Following Strategy with Strong Technicals and Growth Momentum
iRhythm Technologies (IRTC) aligns with Mark Minervini's trend-following strategy, showing strong technicals, rising revenue, and earnings growth. A top performer in healthcare, IRTC is near its... 
Via Chartmill

Performance

YTD
+77.2%
+77.2%
1 Month
+16.6%
+16.6%
3 Month
+15.0%
+15.0%
6 Month
+44.7%
+44.7%
1 Year
+145.2%
+145.2%

More News

Read More
iRhythm (IRTC) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence
iRhythm (IRTC) Q2 Revenue Jumps 26%
Via The Motley Fool
Earnings Scheduled For July 31, 2025
Via Benzinga
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
Via Benzinga
iRhythm (IRTC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Law Enforcement World Trade
Breaking Down iRhythm Technologies: 4 Analysts Share Their Views
Via Benzinga
iRhythm Technologies Inc (NASDAQ:IRTC) Q2 2025 Earnings: Revenue Beat and Narrower Loss Surprise Analysts
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
iRhythm (NASDAQ:IRTC) Delivers Strong Q2 Numbers, Stock Soars
Via StockStory
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
From iRhythm
Via GlobeNewswire
iRhythm Technologies Announces Second Quarter 2025 Financial Results
From iRhythm
Via GlobeNewswire
What To Expect From iRhythm’s (IRTC) Q2 Earnings
Via StockStory
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
From Kahn Swick & Foti, LLC
Via Business Wire
1 Russell 2000 Stock Worth Your Attention and 2 Facing Challenges
Via StockStory
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
From iRhythm
Via GlobeNewswire
1 Healthcare Stock on Our Buy List and 2 to Brush Off
Via StockStory
Topics Stocks
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
Via FinancialNewsMedia
Topics Artificial Intelligence
iRhythm (IRTC) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
From iRhythm
Via GlobeNewswire
Patient Monitoring Stocks Q1 In Review: iRhythm (NASDAQ:IRTC) Vs Peers
Via StockStory
Topics Artificial Intelligence
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
From Kahn Swick & Foti, LLC
Via Business Wire
1 Growth Stock with Impressive Fundamentals and 2 to Be Wary Of
Via StockStory
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
From iRhythm
Via GlobeNewswire

Frequently Asked Questions

Is iRhythm Technologies, Inc. - Common Stock publicly traded?
Yes, iRhythm Technologies, Inc. - Common Stock is publicly traded.
What exchange does iRhythm Technologies, Inc. - Common Stock trade on?
iRhythm Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for iRhythm Technologies, Inc. - Common Stock?
The ticker symbol for iRhythm Technologies, Inc. - Common Stock is IRTC on the Nasdaq Stock Market
What is the current price of iRhythm Technologies, Inc. - Common Stock?
The current price of iRhythm Technologies, Inc. - Common Stock is 158.50
When was iRhythm Technologies, Inc. - Common Stock last traded?
The last trade of iRhythm Technologies, Inc. - Common Stock was at 08/08/25 04:00 PM ET
What is the market capitalization of iRhythm Technologies, Inc. - Common Stock?
The market capitalization of iRhythm Technologies, Inc. - Common Stock is 4.66B
How many shares of iRhythm Technologies, Inc. - Common Stock are outstanding?
iRhythm Technologies, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.